Anna Margarete Maria Thurner
YOU?
Author Swipe
View article: A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials
A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials Open
Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on prede…
View article: A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials
A scoping review of thresholds for responder and time‐to‐event analysis of patient‐reported outcomes in breast cancer trials Open
Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on prede…
View article: The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes
The use of EORTC QLQ-C30 Summary Score in cancer research and its performance as compared with the EORTC QLQ-C30 Global Health/Quality of Life scale: A systematic review and comparative analysis of effect sizes Open
This study indicates that the Summary Score more effectively detects differences in HRQoL than the Global Health/QoL scale. This advantage was most evident in cross-sectional known-group comparisons and, to a lesser extent, in analyses of …
View article: P17.38.B THE USE OF EORTC QLQ-C30 SUMMARY SCORE IN CANCER CLINICAL TRIALS AND ITS PERFORMANCE AS COMPARED WITH THE GLOBAL HEALTH / QUALITY OF LIFE SCALE: A COMPARATIVE ANALYSIS OF EFFECT SIZES
P17.38.B THE USE OF EORTC QLQ-C30 SUMMARY SCORE IN CANCER CLINICAL TRIALS AND ITS PERFORMANCE AS COMPARED WITH THE GLOBAL HEALTH / QUALITY OF LIFE SCALE: A COMPARATIVE ANALYSIS OF EFFECT SIZES Open
BACKGROUND The EORTC QLQ-C30 is the most commonly used questionnaire for assessing general aspects of health-related quality of life (HRQoL) in patients with brain tumors. The summary score provides an overall measure of HRQoL based on 27 …
View article: Lack of precision in the reporting of sex and gender in cancer clinical trials with a PRO endpoint: a systematic review
Lack of precision in the reporting of sex and gender in cancer clinical trials with a PRO endpoint: a systematic review Open
Background Sex and gender are acknowledged as pivotal variables in clinical research. However, the differences between the concepts are frequently neglected in medical research, resulting in limited generalizability of research findings an…
View article: Cancer‐Specificity of Sex Differences and Sex‐Specific Impact of Sociodemographic Characteristics in Cancer Patients' Health‐Related Quality of Life: A Cross‐Sectional Study
Cancer‐Specificity of Sex Differences and Sex‐Specific Impact of Sociodemographic Characteristics in Cancer Patients' Health‐Related Quality of Life: A Cross‐Sectional Study Open
Background Health‐related quality of life (HRQoL) is a multi‐dimensional concept commonly assessed in patient‐centered research on the impact of cancer and its treatment. Apart from disease and treatment characteristics, HRQoL is also infl…
View article: Information about missing patient-reported outcome data in breast cancer trials is frequently not documented: a scoping review
Information about missing patient-reported outcome data in breast cancer trials is frequently not documented: a scoping review Open
International efforts to raise awareness of the importance of accurately reporting state-of-the-art handling of missing PRO data are not yet fully reflected in the current literature of breast cancer RCTs.